Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/30/2010WO2010111460A1 Inhibitors of nf-kb
09/30/2010WO2010111449A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010WO2010111437A1 Antiviral compounds and uses thereof
09/30/2010WO2010111436A2 Antiviral compounds and uses thereof
09/30/2010WO2010111432A1 Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010WO2010111418A2 Process for the production of fused, tricyclic sulfonamides
09/30/2010WO2010111406A2 Compounds and therapeutic uses thereof
09/30/2010WO2010111374A2 Compositions and methods for alleviating skin disorders
09/30/2010WO2010111353A1 N-substituted piperidine derivatives as serotonin receptor agents
09/30/2010WO2010111294A1 Methods for preventing and treating radiation-induced epithelial disorders
09/30/2010WO2010111290A1 Methods and compositions related to modified guanine bases for controlling off-target effects in rna interference
09/30/2010WO2010111257A2 Targeted schiff base complexes
09/30/2010WO2010111218A1 Method for increasing energy in hiv and/or aids patients
09/30/2010WO2010111172A1 Methods of treatment using combination therapy
09/30/2010WO2010111136A2 Aliskiren modulation of neurogenesis
09/30/2010WO2010111116A1 Fluoroquinolone carboxylic acid molecular crystals
09/30/2010WO2010111108A2 Compositions and methods for the treatment of wounds
09/30/2010WO2010111080A2 Optimized treatment of schizophrenia
09/30/2010WO2010111060A1 P2x3, receptor antagonists for treatment of pain
09/30/2010WO2010111059A1 P2x3 receptor antagonists for treatment of pain
09/30/2010WO2010111058A1 P2x3, receptor antagonists for treatment of pain
09/30/2010WO2010111057A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010WO2010111056A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010WO2010111050A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010WO2010110993A2 Methods and compositions for the treatment of cancer
09/30/2010WO2010110923A2 Prophylactic and therapeutic treatment of alzheimer's disease
09/30/2010WO2010110908A2 Transdermal venous access locking solution
09/30/2010WO2010110907A1 Diaminopteridine derivatives
09/30/2010WO2010110887A1 Fatty acids
09/30/2010WO2010110882A1 Absorption barrier and method of using the same
09/30/2010WO2010110817A1 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
09/30/2010WO2010110760A1 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
09/30/2010WO2010110748A1 Use of andrographolide compounds for treating inflammation and airway disorders
09/30/2010WO2010110747A1 Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
09/30/2010WO2010110689A1 A novel medical use of kynurenic acid, its precursors and derivatives
09/30/2010WO2010110686A1 Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
09/30/2010WO2010110684A1 Nitric oxide donors
09/30/2010WO2010110647A1 Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases
09/30/2010WO2010110646A1 Aurones as selective pde inhibitors and their use in neurological conditions and disorders
09/30/2010WO2010110479A1 Activator for peroxisome proliferator-activated receptor
09/30/2010WO2010110471A1 Lipid membrane structure
09/30/2010WO2010110440A1 Novel therapeutic agent for cognitive impairment
09/30/2010WO2010110436A1 Matrix-type sustained release preparation containing basic additive
09/30/2010WO2010110428A1 Prophylactic and/or therapeutic agent for pruritus
09/30/2010WO2010110414A1 Indazolepropionic acid amide compound
09/30/2010WO2010110400A1 Heterocyclic compound
09/30/2010WO2010110380A1 Fused piperidine compound and pharmaceutical agent comprising same
09/30/2010WO2010110378A1 Pyrazole compound
09/30/2010WO2010110374A1 Agent for enhancing hypoglycemic activity
09/30/2010WO2010110361A1 Method for producing bicyclic γ-amino acid derivative
09/30/2010WO2010110353A1 Novel amide derivative and skin whitening agent
09/30/2010WO2010110352A1 Process for producing carboxylic acid compound
09/30/2010WO2010110334A1 Readily water-soluble myricitrin composition
09/30/2010WO2010110328A1 Readily water-soluble isoquercitrin composition
09/30/2010WO2010110318A1 Therapeutic agent for arteriosclerotic diseases comprising nucleic acid
09/30/2010WO2010110314A1 Therapeutic agent for pulmonary hypertension comprising nucleic acid
09/30/2010WO2010110313A1 Pharmaceutical composition for prevention or treatment of lifestyle-related disease, and food useful for prevention or treatment of lifestyle-related disease
09/30/2010WO2010110268A1 Pharmaceutical agent for preventing cell death
09/30/2010WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative
09/30/2010WO2010110223A1 Fucoidan having antitumor activity
09/30/2010WO2010110220A1 Dispersion and manufacturing method therefor
09/30/2010WO2010110026A1 Pharmaceutical composition for metabolic syndrome, obesity, hyperglycemia, hyperlipemia and/or fatty liver
09/30/2010WO2010110018A1 Coated solid preparation
09/30/2010WO2010109961A1 Burdock fruit extract containing arctigenin at high content and process for producing same
09/30/2010WO2010109913A1 Transdermal preparation
09/30/2010WO2010109736A1 Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage
09/30/2010WO2010109687A1 Coral-derived therapeutic agent for inflammations and allergic diseases
09/30/2010WO2010109628A1 Pharmaceutical composition for enhancing adiponectin production and food useful therefor
09/30/2010WO2010109626A1 Pharmaceutical composition for prevention or treatment of lifestyle-related diseases and food useful therefor
09/30/2010WO2010109544A1 Composition for external application containing nucleic acid as active ingredient
09/30/2010WO2010109511A1 Use of microrna-199b-5p in medical and diagnostic field
09/30/2010WO2010109482A2 Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions
09/30/2010WO2010109475A1 A sustained release oral composition of an antipsychotic agent
09/30/2010WO2010109450A1 Rhodamine 6g for use in treating cancerous cells
09/30/2010WO2010109434A2 A medicinal antibacterial, antifungal and steroids cream and a process to make it
09/30/2010WO2010109433A1 An antiviral medicinal cream and a process to make it
09/30/2010WO2010109432A1 An antiscabies medicinal cream and a process to make it
09/30/2010WO2010109425A2 A medicinal steroids cream and a process to make it
09/30/2010WO2010109424A1 A medicinal antibacterial and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109423A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109421A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109420A1 A medicinal anti acne cream comprising chitosan and a process to make it
09/30/2010WO2010109386A1 Method for the industrial purification of biologically active phycotoxins
09/30/2010WO2010109329A1 Furopyrimidinedione derivatives as trpa1 modulators
09/30/2010WO2010109328A1 Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
09/30/2010WO2010109287A1 Fused pyrimidine-dione derivatives as trpa1 modulators
09/30/2010WO2010109259A1 Method for preparing soft gel formulations of liquid isotretinoin and formulations obtained
09/30/2010WO2010109257A1 Composition to treat protein intolerance
09/30/2010WO2010109256A1 Enhanced treatment of joint and connective tissue damage
09/30/2010WO2010109230A1 Novel prodrugs
09/30/2010WO2010109172A1 Mannich base tetraoxanes (mannoxanes) and phenol substituted analogues
09/30/2010WO2010109150A1 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof
09/30/2010WO2010109148A1 Therapeutic uses of quinazolinedione derivatives
09/30/2010WO2010109123A1 Anticancer derivatives, preparation thereof, and therapeutic use thereof
09/30/2010WO2010109122A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
09/30/2010WO2010109115A1 Anticancer compounds, preparation thereof, and therapeutic use thereof
09/30/2010WO2010109093A1 Water soluble defructosylated pea extract, and use thereof as a prebiotic agent
09/30/2010WO2010109050A1 Cromenopyrazole derivatives as cannabinoid receptor ligands
09/30/2010WO2010109017A1 Mirna and its targets respectively the proteins made based on the targets as a prognostic, diagnostic biomarker and therapeutic agent for cancer
09/30/2010WO2010109016A1 Kanamycin antisense nucleic acid for the treatment of cancer
1 ... 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 ... 7860